Abiopharma

Galligan Andrew H 🔴 sold 23.6K shares (2 derivative) of Arcellx, Inc. (ACLX) at $69.87 ($1.3M) Transaction Date: Apr 28, 2026 | Filing ID: 000002

(50% Neutral) SEVEN HILLS REALTY TRUST (SEVN) Files Form 8-K

(30% Negative) EXTRA SPACE STORAGE INC. (EXR) Reports Q2 2026 Financial Results

Gilson Michelle 🟡 adjusted position in 480.8K shares (9 derivative) of Arcellx, Inc. (ACLX) at $56.15 ($8.5M) Transaction Date: Apr 28, 2026 | Filing ID: 000008

Daunt John 🔴 sold 260.6K shares (19 derivative) of LIQUIDITY SERVICES INC (LQDT) at $35.06 ($3.1M) Transaction Date: Apr 24, 2026 | Filing ID: 000011

(50% Neutral) FRANKLIN STREET PROPERTIES CORP /MA/ (FSP) Reports Q2 2026 Financial Results

Heery Christopher 🟡 adjusted position in 506.9K shares (11 derivative) of Arcellx, Inc. (ACLX) at $56.15 ($8.9M) Transaction Date: Apr 28, 2026 | Filing ID: 000010

Director Gilmer Daniel B. 🟢 acquired 51.3K shares (1 derivative) of Armata Pharmaceuticals, Inc. (ARMP) at $12.92 Transaction Date: Apr 24, 2026 | Filing ID: 050391

(50% Neutral) FIRSTENERGY CORP (FE) Reports Q2 2026 Financial Results

Director PYOTT DAVID E I 🟡 adjusted position in 0 shares (1 derivative) of Tarsus Pharmaceuticals, Inc. (TARS) Transaction Date: Apr 24, 2026 | Filing ID: 000006